Loading clinical trials...
Loading clinical trials...
The objective of this study is to evaluate the safety and efficacy of loteprednol etabonate (LE) ophthalmic gel, 0.38% (BID)
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bausch & Lomb Incorporated
NCT06885931 · Mixed Urinary Incontinence, Stress Urinary Incontinence (SUI), and more
NCT07590050 · Lumbar Spondylosis, Low Back Pain
NCT06616506 · Cataract, High Myopia, and more
NCT07011394 · Diagnosis, Inflammation, and more
NCT06665204 · Patellofemoral Pain
Bausch & Lomb Incorporated
Bridgewater, New Jersey
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions